Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Government tightens surveillance on GLP-1 weight-loss drug promotion amidst surrogate advertising concerns

The Central government, amidst rising concerns over surrogate advertising and misleading awareness campaigns, directed regulators across states and Union Territories to tighten surveillance over the supply chain and promotion of GLP-1 weight-loss drugs.

The Minister of State for Health Anupriya Patel, in a written reply in the Rajya Sabha on Tuesday said glucagon-like peptide-1 (GLP-1) receptor agonists has been approved by the Central Drugs Standard Control Organisation (CDSCO) only for the treatment of Type 2 diabetes in adults and for chronic weight management in adults with specific medical conditions.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.